Key result
The Ugandan version of the MMAS-8 demonstrated moderate internal consistency and low test-retest reliability for measuring antihypertensive medication adherence.
Why the study?
Is the translated MMAS-8 (MMAS-U) a valid and reliable measure of antihypertensive medication adherence in Ugandan outpatients?
Cross-Sectional (n=329)
No
Is the translated MMAS-8 (MMAS-U) a valid and reliable measure of antihypertensive medication adherence in Ugandan outpatients?
The translated MMAS-8 is a valid tool with moderate internal consistency for assessing antihypertensive medication adherence in Ugandan outpatients, revealing a high prevalence of low adherence.
Answers are grounded in this paper and cite their sources.
Caution warranted against routine clinical use of the Ugandan MMAS-8; leaves open the need for better-validated adherence tools in this population.
BACKGROUND: The Morisky Medication Adherence scale (MMAS-8) is a widely used self-reported measure of adherence to antihypertensive medications that has not been validated in hypertensive patients in sub-Saharan Africa. METHODS: We carried out a cross-sectional study to examine psychometric properties of a translated MMAS-8 (MMAS-U) in a tertiary care hypertension clinic in Uganda. We administered the MMAS-U to consecutively selected hypertensive adults and used principal factor analysis and Cronbach's alpha to determine its validity and internal consistency respectively. Then we randomly selected one-sixth of participants for a 2-week test-retest telephone interview. Lastly, we used ordinal logistic regression modeling to explore factors associated with levels of medication adherence. RESULTS: Of the 329 participants, 228 (69%) were females, median age of 55 years [Interquartile range (IQR) (46-66)], and median duration of hypertension of 4 years [IQR (2-8)]. The adherence levels were low (MMAS-U score ≤ 5) in 85%, moderate (MMAS-U score 6-7) in 12% and high (MMAS-U score ≥8) in 3%. The factor analysis of construct validity was good (overall Kaiser's measure of sampling adequacy for residuals of 0.72) and identified unidimensionality of MMAS-U. The internal consistency of MMAS-U was moderate (Cronbach α = 0.65), and test-retest reliability was low (weighted kappa = 0.36; 95% CI -0.01, 0.73). Age of 40 years or greater was associated with low medication adherence (p = 0.02) whereas a family member buying medication for participants (p = 0.02) and purchasing medication from a private clinic (p = 0.02) were associated with high adherence. CONCLUSION: The Ugandan version of the MMAS-8 (MMAS-U) is a valid and reliable measure of adherence to antihypertensive medication among Ugandan outpatients receiving care at a public tertiary facility. Though the limited supply of medication affected adherence, this easy to use tool can be adapted to assess medication adherence among adults with hypertension in Uganda.
No takes yet. Share an insight, caveat, or question.
Okello et al. (2016) conducted a cross-sectional in Hypertension (n=329). Translated Morisky Medication Adherence Scale (MMAS-U) was evaluated on Test-retest reliability (weighted kappa) (weighted kappa 0.36, 95% CI -0.01, 0.73, p=<0.001). The Ugandan version of the MMAS-8 demonstrated moderate internal consistency and low test-retest reliability for measuring antihypertensive medication adherence.
Synapse has enriched 10 related papers. Consider them for comparative context: